The novel approach of tirzepatide peptide represents a major advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and GIP – providing greater sugar management and potential weight reduction. Researchers are investigating its long-term advantages and part in the complete di… Read More